Our Services

 

About Us

Excellentia Global Partners

Excellentia Global Partners works with Life Science Companies, Medical Device, Diagnostic / Proteomics companies. Your innovation equals innovative thinking and together we work along the continuum of success.

 

What We Do

EGP connects our life science clients with sources of capital in the Venture Capital and Private Equity arena. EGP is committed to achieving creative solutions through the utilization of its network.

“….the world thrives on innovation an creative thinking. EGP enables companies and the innovation they represent, to grow and blossom, through the EGP network, time and advice.”

EGP has developed a connected network focused on providing the foundation for success. This connected network forms the basis to advise companies on their varying needs for capital, strategic partnerships and licensing opportunities.

 
 

Our Network

team

Beth Jacobs

Managing Partner

Beth Jacobs currently serves as Managing Partner of Excellentia Global Partners, a global life sciences investment bank, founded in 2008. Excellentia Global Partners works closely with early stage biotech and medical device companies, raising capital and enabling critical licensing and partnering with Big Pharma companies. Prior to establishing Excellentia Global Partners, Beth was a General Partner at Bio-IB, a life science-focused investment bank in New York.

Beth has served in senior executive roles in her twenty five years of experience in both investment banking and in the corporate sector. Prior to 2003, Beth served as Senior Vice President for Laureate Education (NASDAQ: LAUR), a $3 billion market cap company in the education sector. She worked across all business units in a corporate development role, with a distinct focus on identifying and executing on opportunities in China.

Beth was Managing Director and Co-Head of Global Capital Markets at ING Barings, shortly after their acquisition of Furman Selz LLC, where she founded and led its international institutional equity group for over 9 years. She started her career at Prudential Securities where she founded the international institutional equity business, and later headed the same product execution group at both Morgan Stanley and Lehman Brothers.

She currently serves on the Board of Directors of EF Foundation, a global educational services company based in Stockholm and Cambridge, Mass, the Supervisory Board of Genomic Vision (GV listed on Euronext Exchange /Paris in DNA analysis), founding Global Ambassador for Susan G. Komen for the Cure, Board member for the Harvard Kennedy School of Government Women’s Leadership Board, Director of the William J. von Liebig Foundation, Board of Governors of the New York Academy of Sciences where she serves as Chair of the Investment Committee, Governance and Executive Committees. Previously, Beth served for 7 years as the Vice Chairman of the Friends of the Budapest Festival Orchestra.

Beth received an MBA in international finance from American University in Washington, DC in conjunction with the School of Foreign Service, and a BA, cum laude, from Boston College. She also studied at Centre d’Etudes Internationale in Geneva, Switzerland. Beth is fluent in French.

 

STRATEGIC WORLDWIDE ADVISORY TEAM

EGP is proud to have a world class group of advisors who assist in vetting ideas and providing strategic advice. This group of world renowned professionals bring expertise in Regulatory Affairs, Clinical Development, Basic Scientific expertise and Commercialization.

Peter K Honig
M.D., M.P.H.

Peter Honig is Senior Vice President of Worldwide Regulatory Affairs and Safety and...

Keith M. Gottesdiener
M.D., Chief Executive Officer

Dr. Gottesdiener has been our Chief Executive Officer and a member of our board of directors since...

Barry C. Buckland
PHD

PhD in Biochemical Engineering at University College London obtained in 1974. Joined the Merck...

 

Contact Us

We look forward to working with you. Please contact us:

EGP consider ourselves extensions of our clients as we navigate the worlds of financing strategies and growth, using our vast network.

Leave Message

Lorem ipsum is simply dummy text of the printing and typesetting industry.